Who owns PHARMACYTE BIOTECH INC?
- Ticker: PMCB
- CUSIP Number: 71715x203
Tip: Access positions for across all investors
Analyze quarterly positions in Pharmacyte Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharmacyte Biotech stock
Who bought or sold PHARMACYTE BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hrt Financial | 183k | $132k | 100% | Dec 2025 |
|
| Geode Capital Management | 124k | $90k | -2% | Dec 2025 |
|
| Sabby Management | 100k | $72k | 100% | Dec 2025 |
|
| Renaissance Technologies | 94k | $68k | 18% | Dec 2025 |
|
| Vanguard Group | 75k | $54k | 0% | Dec 2025 |
|
| Northern Trust | 36k | $26k | 85% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 26k | $19k | 0% | Dec 2025 |
|
| Simplex Trading | 26k | $19k | 2249% | Dec 2025 |
|
| Citadel Advisors | 25k | $24k | 100% | Sep 2025 |
|
| Two Sigma Securities | 25k | $18k | 100% | Dec 2025 |
|
| XTX Topco | 24k | $18k | 100% | Dec 2025 |
|
| Equitec Proprietary Markets | 22k | $16k | -73% | Dec 2025 |
|
| Jane Street | 11k | $8.3k | 100% | Dec 2025 |
|
| Tower Research Capital | 4.9k | $3.5k | -12% | Dec 2025 |
|
| UBS Group | 2.7k | $2.0k | 108% | Dec 2025 |
|
| Advisor Group Holdings | 303.00 | $303.000000 | 0% | Dec 2025 |
|
| Covestor | 275.00 | $0 | 0% | Dec 2025 |
|
| Accredited Wealth Management | 50.00 | $1.000000 | 100% | Sep 2025 |
|
| Sachetta | 14.00 | $10.999800 | 0% | Dec 2025 |
|
| Aviso Financial | 12.00 | $8.000400 | 100% | Dec 2025 |
|
| BFSG | 5.00 | $4.000000 | 0% | Dec 2025 |
|
| Financial Consulate | 2.00 | $2.000000 | 0% | Dec 2025 |
|
| Goss Wealth Management | 2.00 | $1.000000 | 0% | Dec 2025 |
|
| CWM | 1.00 | $0 | 0% | Dec 2025 |
|
| IFP Advisors | 1.00 | $1.000000 | 0% | Dec 2025 |
|
| MCF Advisors | 1.00 | $1.000000 | 100% | Dec 2025 |
|
| BlackRock | 1.00 | $1.000000 | 0% | Dec 2025 |
|